Gene signature could improve early diagnosis of TB

Researchers have identified a gene signature in the bloodstream that could determine whether a person is going to develop active tuberculosis (TB), months before they show any symptoms of the infection.

Image Credit: Tatiana Shepeleva / Shutterstock

The finding comes from a study led by the Francis Crick Institute and University of Leicester, in collaboration with BIOASTER and bioMerieux in France and the University of Cape Town in South Africa.

As reported in the journal Nature Communications, the researchers looked at 53 patients who had TB and followed 108 of their close contacts over two years to see who developed active disease.

The team found that individuals who stayed healthy had no sustained gene signature, while six of nine people who developed active TB had a strong, sustained signature.

In this multidisciplinary team effort, we hope to address the unmet medical need of diagnosing active tuberculosis earlier, more easily and more reliably."

Mark Miller, Chief Medical Officer, bioMérieux

This gene 'signature' refers to the group of genes that are either more or less active during active TB, which indicates how the body has responded to the infection.

This is the first time the presence of such a signature has been linked to early TB onset, before symptoms have developed.

The study could have important implications for the detection and treatment of TB, as well as for the possibility of intervening before people with TB pose a risk of transmitting the infection to others.

Treating active TB before symptoms start could spare patients and their families from unpleasant symptoms, reduce the spread of disease and offer peace of mind to people who are not going to develop active TB.”

Professor Anne O’Garra, Senior Author

Next, the team plans to investigate what the different responses mean, which will require detailed study of larger groups of people.

Their ultimate goal is to develop and test different gene signatures in larger groups of people, with the aim of being able to offer validated tests to patients within the next decade.

There was a wide variation in the immune response between people, highlighting the limitations of taking a 'one size fits all' approach... We only saw a small number of contacts who developed TB in the group, so we will need to look at much larger groups to refine and develop the techniques”

Dr Pranab Haldar, Co-Author

Sally Robertson

Written by

Sally Robertson

Sally first developed an interest in medical communications when she took on the role of Journal Development Editor for BioMed Central (BMC), after having graduated with a degree in biomedical science from Greenwich University.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Robertson, Sally. (2019, June 24). Gene signature could improve early diagnosis of TB. News-Medical. Retrieved on May 15, 2021 from https://www.news-medical.net/news/20180619/Gene-signature-could-improve-early-diagnosis-of-TB.aspx.

  • MLA

    Robertson, Sally. "Gene signature could improve early diagnosis of TB". News-Medical. 15 May 2021. <https://www.news-medical.net/news/20180619/Gene-signature-could-improve-early-diagnosis-of-TB.aspx>.

  • Chicago

    Robertson, Sally. "Gene signature could improve early diagnosis of TB". News-Medical. https://www.news-medical.net/news/20180619/Gene-signature-could-improve-early-diagnosis-of-TB.aspx. (accessed May 15, 2021).

  • Harvard

    Robertson, Sally. 2019. Gene signature could improve early diagnosis of TB. News-Medical, viewed 15 May 2021, https://www.news-medical.net/news/20180619/Gene-signature-could-improve-early-diagnosis-of-TB.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.